Evidence map›Paper›PMID 39169387›Full record

ArticleClinical epigenetics2024

The response to influenza vaccination is associated with DNA methylation-driven regulation of T cell innate antiviral pathways.

Hongxiang Fu, Harry Pickering, Liudmilla Rubbi, Ted M Ross, Wanding Zhou, Elaine F Reed, Matteo Pellegrini

Abstract read
In one paragraph

Article in Clinical epigenetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Hongxiang FuDepartment of Molecular Cell and Developmental Biology, University of California Los Angeles, Los Angeles, CA, USA.
Harry PickeringDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Liudmilla RubbiDepartment of Molecular Cell and Developmental Biology, University of California Los Angeles, Los Angeles, CA, USA.
Ted M RossDepartment of Infectious Diseases, University of Georgia, Athens, GA, USA.
Wanding ZhouCenter for Computational and Genomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Elaine F ReedDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Matteo PellegriniDepartment of Molecular Cell and Developmental Biology, University of California Los Angeles, Los Angeles, CA, USA. matteop@g.ucla.edu.

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,75N93019C00052 · NIAID · UNIVERSITY OF GEORGIA · PI ROSS, TED · 2019 to 2025
$74.6M
NCATS NIH HHS UL1 TR002378NCATS NIH HHS UL1TR002378NIAID NIH HHS 75N93019C00052University of Georgia UGA-001
6 · The paper itself

Abstract

backgroundThe effect of vaccination on the epigenome remains poorly characterized. In previous research, we identified an association between seroprotection against influenza and DNA methylation at sites associated with the RIG-1 signaling pathway, which recognizes viral double-stranded RNA and leads to a type I interferon response. However, these studies did not fully account for confounding factors including age, gender, and BMI, along with changes in cell-type composition.

resultsHere, we studied the influenza vaccine response in a longitudinal cohort vaccinated over two consecutive years (2019-2020 and 2020-2021), using peripheral blood mononuclear cells and a targeted DNA methylation approach. To address the effects of multiple factors on the epigenome, we designed a multivariate multiple regression model that included seroprotection levels as quantified by the hemagglutination-inhibition (HAI) assay test.

conclusionsOur findings indicate that 179 methylation sites can be combined as potential signatures to predict seroprotection. These sites were not only enriched for genes involved in the regulation of the RIG-I signaling pathway, as found previously, but also enriched for other genes associated with innate immunity to viruses and the transcription factor binding sites of BRD4, which is known to impact T cell memory. We propose a model to suggest that the RIG-I pathway and BRD4 could potentially be modulated to improve immunization strategies.

Indexed as

DNA MethylationImmunity, InnateInfluenza, HumanInfluenza VaccinesAdultDEAD Box Protein 58Epigenesis, GeneticFemaleHumansLeukocytes, MononuclearLongitudinal StudiesMaleMiddle AgedSignal TransductionT-LymphocytesVaccinationDEAD Box Protein 58Influenza VaccinesCell-type deconvolutionDNA methylationInfluenza vaccineInfluenza virusRNA sequencingTargeted bisulfite sequencing

Identifiers

PMID39169387
PMCPMC11340180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.